Air pollution and cardiopulmonary health: Susceptibility by HIV infection status
空气污染与心肺健康:艾滋病毒感染状况的易感性
基本信息
- 批准号:10458456
- 负责人:
- 金额:$ 13.18万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-08-01 至 2024-07-31
- 项目状态:已结题
- 来源:
- 关键词:AdultAdvisory CommitteesAfricanAgeAirAir PollutionBlood PressureCarbon BlackCarbon MonoxideCardiopulmonaryCardiopulmonary PhysiologyCardiovascular DiseasesCardiovascular systemCessation of lifeChronic Obstructive Pulmonary DiseaseClinicClinical ResearchCoalCountryDeath RateDevelopmentDevelopment PlansDiseaseEpidemiologyExposure toForced expiratory volume functionFoundationsGeneral PopulationGenerationsGoalsGuidelinesHIVHIV InfectionsHIV SeronegativityHealthHourHouseholdHypertensionInfectionInflammationInterventionKeroseneLifeLife ExpectancyLungMeasurementMeasuresMedicineMentorsMentorshipMiningMorbidity - disease rateMyocardial InfarctionNitrogen DioxideOutcomeParticipantParticulate MatterPersonsPoliciesPopulationPredispositionPrevalencePrevention strategyPulmonary Function Test/Forced Expiratory Volume 1Pulmonary Heart DiseaseResearchResearch TrainingRespiratory DiseaseRiskRisk FactorsSmokingSourceSouth AfricaSpirometryStandardizationSubgroupTimeTrainingVirus DiseasesVital capacityVulnerable PopulationsWomanWood materialWorkWorld Health Organizationantiretroviral therapyblood pressure elevationburden of illnesscardiovascular risk factorcareercareer developmentchronic infectioncomorbiditydisorder riskexperiencefine particleshigh riskmenmodifiable riskmortalitypeerperi-urbanprematurepreventpreventive interventionpulmonary functionrespiratorysecondary outcometreatment strategy
项目摘要
PROJECT SUMMARY/ABSTRACT
Air pollution is a leading cause of mortality globally, contributing to nearly 1 in 10 deaths and 147 million years
of healthy life lost annually. Fine particulate matter (PM2.5) is a key component of air pollution; it is highly
regulated and is the component of the air pollution mixture most consistently and strongly associated with
cardiovascular and respiratory mortality. While exposure to PM2.5 is associated with adverse cardiopulmonary
effects in the general population, associations are even stronger among susceptible populations, including
those with preexisting cardiovascular or respiratory disease. Identifying subgroups experiencing differential
PM2.5-related health effects is key to informing policy and intervention strategies to protect our most vulnerable
populations. There are 38 million people with human immunodeficiency virus (HIV) infection worldwide and 1.7
million new HIV infections each year. Improvements in antiretroviral therapy have led to longer life
expectancies for people with HIV, but other health risks have arisen from chronic infection. Cardiopulmonary
disease is a leading cause of morbidity and mortality among people with HIV due to long-term inflammation
from infection as well as some antiretroviral therapy. Further, people with HIV may be at higher risk for adverse
cardiopulmonary health effects from traditional risk factors as compared to the general population. The majority
of the world's population is exposed to PM2.5 levels higher than the World Health Organization's (WHO)
guideline for healthy air, but it is unknown if people with HIV are more susceptible to cardiopulmonary disease
resulting from this exposure than the general population. The specific aims of this project are to 1) examine
HIV infection as a potential modifier of the association between PM2.5 and systolic blood pressure, and 2)
examine HIV infection as a potential modifier of the association between PM2.5 and percent predicted forced
expiratory volume in the first second (FEV1). This study will take place in Matlosana, South Africa, a peri-urban
district experiencing a confluence of high HIV prevalence and ambient PM2.5 levels regularly exceeding the
WHO's 24-hour guideline of 25 µg/m3. With 7.5 million people with HIV, South Africa has the highest absolute
burden of HIV in the world and an increasing burden of cardiovascular disease and chronic obstructive
pulmonary disease (COPD). South Africa also has the second highest age-standardized death rate attributable
to air pollution among all sub-Saharan African countries. The career development plan includes didactic and
experiential training in cardiopulmonary physiology and air pollution exposure assessment, which will help the
candidate implement the current project with fidelity and achieve her long-term goals of reducing air pollution
exposure and prevent cardiopulmonary disease among people with HIV. She will have the support of a
mentoring team and Advisory Committee with extensive experience in air pollution epidemiology and
measurement, HIV clinical research, and cardiopulmonary physiology and health outcomes.
项目概要/摘要
空气污染是全球死亡的主要原因,造成近十分之一的死亡和 1.47 亿年
每年损失的健康生命。细颗粒物 (PM2.5) 是空气污染的一个重要组成部分;
受到监管,并且是空气污染混合物中与以下因素最一致且密切相关的组成部分:
心血管和呼吸系统死亡率。而暴露于 PM2.5 与心肺不良有关。
对一般人群的影响,在易感人群中的关联性甚至更强,包括
那些患有先前存在的心血管或呼吸系统疾病的人识别经历差异的亚组。
PM2.5 相关的健康影响是为保护我们最弱势群体的政策和干预策略提供信息的关键
全球有 3800 万人感染人类免疫缺陷病毒 (HIV),其中 1.7 人感染艾滋病毒。
每年有 100 万人感染艾滋病毒,抗逆转录病毒治疗的改进导致寿命延长。
艾滋病毒感染者的期望,但慢性感染还产生了其他健康风险。
由于长期炎症,这种疾病是艾滋病毒感染者发病和死亡的主要原因
此外,艾滋病毒感染者可能面临更高的不良风险。
与一般人群相比,传统危险因素对心肺健康的影响。
世界人口接触的 PM2.5 水平高于世界卫生组织 (WHO) 的水平
健康空气指南,但尚不清楚艾滋病毒感染者是否更容易患心肺疾病
该项目的具体目标是 1) 检查
HIV 感染是 PM2.5 与收缩压之间关联的潜在调节因素,2)
检查 HIV 感染是否是 PM2.5 与预测强制百分比之间关联的潜在修正因素
第一秒呼气量 (FEV1) 这项研究将在南非马特洛萨纳 (Matlosana) 的一个城郊进行。
该地区艾滋病毒高感染率和环境 PM2.5 水平经常超过正常水平
世界卫生组织的 24 小时指导值是 25 µg/m3,南非有 750 万艾滋病毒感染者,绝对值最高。
全球艾滋病毒负担以及心血管疾病和慢性阻塞性肺病负担日益增加
南非的年龄标准化死亡率也位居第二。
职业发展计划包括教学和培训。
心肺生理学和空气污染暴露评估的体验式培训,这将有助于
候选人忠实地实施当前项目并实现减少空气污染的长期目标
她将得到艾滋病毒感染者的支持。
指导团队和咨询委员会在空气污染流行病学和
测量、艾滋病毒临床研究以及心肺生理学和健康结果。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jessica L Elf其他文献
Jessica L Elf的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Jessica L Elf', 18)}}的其他基金
Air pollution and cardiopulmonary health: Susceptibility by HIV infection status
空气污染与心肺健康:艾滋病毒感染状况的易感性
- 批准号:
10663889 - 财政年份:2021
- 资助金额:
$ 13.18万 - 项目类别:
Air pollution and cardiopulmonary health: Susceptibility by HIV infection status
空气污染与心肺健康:艾滋病毒感染状况的易感性
- 批准号:
10214785 - 财政年份:2021
- 资助金额:
$ 13.18万 - 项目类别:
相似海外基金
Development and Evaluation of School-based Digital Adolescent Oral Health Promotion Program for the Reduction of Oral Health Disparities
旨在减少口腔健康差异的校本数字青少年口腔健康促进计划的开发和评估
- 批准号:
10745029 - 财政年份:2023
- 资助金额:
$ 13.18万 - 项目类别:
BASE TITLE: PREVENT PRECLINICAL DRUG DEVELOPMENT PROGRAM: PRECLINICAL EFFICACY AND INTERMEDIATE ENDPOINT BIOMAKERSTASK ORDER TITLE: VACCINES AGAINS
基本标题:预防临床前药物开发计划:临床前疗效和中间终点 BIOMAKERSTASK 订单标题:再次疫苗
- 批准号:
10651935 - 财政年份:2022
- 资助金额:
$ 13.18万 - 项目类别:
Baylor College of Medicine Site Consortium - Adolescent Medicine Trials Network for HIV/AIDS Interventions (ATN) Operations and Collaborations Center (UM2 Clinical Trial Optional)
贝勒医学院站点联盟 - HIV/艾滋病干预青少年医学试验网络 (ATN) 运营和合作中心(UM2 临床试验可选)
- 批准号:
10709602 - 财政年份:2022
- 资助金额:
$ 13.18万 - 项目类别:
Impact of Structural Racism and Discrimination on Liver Disease Disparities in High-Risk Asian American Populations
结构性种族主义和歧视对高危亚裔美国人肝病差异的影响
- 批准号:
10474736 - 财政年份:2022
- 资助金额:
$ 13.18万 - 项目类别:
Florida Summer Institute for Biostatistics and Data Science
佛罗里达夏季生物统计和数据科学研究所
- 批准号:
10625970 - 财政年份:2022
- 资助金额:
$ 13.18万 - 项目类别: